Table of contents
Volume 91, Issue 11
Published online 23 November 2004 (1853-1979)
Epidemiology |
Molecular and Cellular Pathology |
Experimental Therapeutics |
Erratum |
Corrigendum
Clinical
Contemporary update of cancer control after radical prostatectomy in the UK FREE
M H Winkler, F A Khan, M Shabir, A Okeke, M Sugiono, P McInerney, G B Boustead, R Persad, A V Kaisary and D A Gillatt
Br J Cancer 91: 1853-1857; advance online publication, November 2, 2004; doi:10.1038/sj.bjc.6602206
Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the Childhood Cancer Survivor Study FREE
R Nagarajan, D R Clohisy, J P Neglia, Y Yasui, P A Mitby, C Sklar, J Z Finklestein, M Greenberg, G H Reaman, L Zeltzer and L L Robison
Br J Cancer 91: 1858-1865; advance online publication, November 9, 2004; doi:10.1038/sj.bjc.6602220
Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group FREE
K N Canfield, L G Spector, L L Robison, D Lazovich, M Roesler, A F Olshan, F O Smith, N A Heerema, D R Barnard, C K Blair and J A Ross
Br J Cancer 91: 1866-1872; advance online publication, November 2, 2004; doi:10.1038/sj.bjc.6602223
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma FREE
I Hus, A Dmoszynska, J Manko, M Hus, D Jawniak, M Soroka-Wojtaszko, A Hellmann, H Ciepluch, A Skotnicki, T Wolska-Smolen, K Sulek, T Robak, L Konopka and J Kloczko for the Polish Multiple Myeloma Study Group
Br J Cancer 91: 1873-1879; advance online publication, November 2, 2004; doi:10.1038/sj.bjc.6602225
Modulation of human V
24+V
11+ NKT cells by age, malignancy and conventional anticancer therapies FREE
T Crough, D M Purdie, M Okai, A Maksoud, M Nieda and A J Nicol
Br J Cancer 91: 1880-1886; advance online publication, November 2, 2004; doi:10.1038/sj.bjc.6602218
Psychological costs of inadequate cervical smear test results FREE
D P French, E Maissi and T M Marteau
Br J Cancer 91: 1887-1892; advance online publication, November 9, 2004; doi:10.1038/sj.bjc.6602224
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer FREE
J Bernhard, D Zahrieh, A S Coates, R D Gelber, M Castiglione-Gertsch, E Murray, J F Forbes, L Perey, J Collins, R Snyder, C-M Rudenstam, D Crivellari, A Veronesi, B Thürlimann, M F Fey, K N Price, A Goldhirsch and C Hürny for the International Breast Cancer Study Group (IBCSG)
Br J Cancer 91: 1893-1901; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602230
Epidemiology
Recent trends in cervical cancer mortality in Britain and Ireland: the case for population-based cervical cancer screening FREE
H Comber and A Gavin
Br J Cancer 91: 1902-1904; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602236
Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain FREE
H C Jenkinson, M M Hawkins, C A Stiller, D L Winter, H B Marsden and M C G Stevens
Br J Cancer 91: 1905-1910; advance online publication, November 9, 2004; doi:10.1038/sj.bjc.6602226
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations FREE
A S Whittemore, R R Balise, P D P Pharoah, R A DiCioccio, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)I Oakley-Girvan, S J Ramus, M Daly, M B Usinowicz, K Garlinghouse-Jones, B A J Ponder, S Buys, R Senie, I Andrulis, E John, J L Hopper and M S Piver
Br J Cancer 91: 1911-1915; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602239
Molecular and Cellular Pathology
TP53 status determines clinical significance of ERBB2 expression in ovarian cancer FREE
J Kupryja
czyk, R M
dry, J Plisiecka-Ha
asa, J Bar, E Kraszewska, I Ziókowska, A Timorek, J Stelmachów, J Emerich, M J
dryka, A Pu
aska, I Rzepka-Górska, K Urbaski, J Zieliski and J Markowska
Br J Cancer 91: 1916-1923; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602238
Overexpression of SPARC gene in human gastric carcinoma and its clinic–pathologic significance FREE
C-S Wang, K-H Lin, S-L Chen, Y-F Chan and S Hsueh
Br J Cancer 91: 1924-1930; advance online publication, November 23, 2004; doi:10.1038/sj.bjc.6602213
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells FREE
D Arango, A J Wilson, Q Shi, G A Corner, M J Arañes, C Nicholas, M Lesser, J M Mariadason and L H Augenlicht
Br J Cancer 91: 1931-1946; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602215
Experimental Therapeutics
Evaluation of hypoxia in an experimental rat tumour model by [18F]Fluoromisonidazole PET and immunohistochemistry FREE
L Dubois, W Landuyt, K Haustermans, P Dupont, G Bormans, P Vermaelen, P Flamen, E Verbeken and L Mortelmans
Br J Cancer 91: 1947-1954; advance online publication, November 2, 2004; doi:10.1038/sj.bjc.6602219
Inherent growth advantage of (pre)malignant hepatocytes associated with nuclear translocation of pro-transforming growth factor
FREE
E Schausberger, K Hufnagl, W Parzefall, C Gerner, D Kandioler-Eckersberger, F Wrba, M Klimpfinger, R Schulte-Hermann and B Grasl-Kraupp
Br J Cancer 91: 1955-1963; advance online publication, November 9, 2004; doi:10.1038/sj.bjc.6602191
Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells FREE
G Giannelli, A Azzariti, E Fransvea, L Porcelli, S Antonaci and A Paradiso
Br J Cancer 91: 1964-1969; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602231
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells FREE
Y M Zhu, S J Webster, D Flower and P J Woll
Br J Cancer 91: 1970-1976; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602227
Erratum
Anticancer drug development: preclinical screening, clinical trials and approval FREE
B A Teicher, D L Selwood and P A Andrews
Br J Cancer 91: 1977; doi:10.1038/sj.bjc.6602286
Corrigendum
Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-
in haematopoietic tumour cells FREE
Y Morimoto, M Toyota, H Ikeda, T Tokino and K Imai
Br J Cancer 91: 1978; doi:10.1038/sj.bjc.6602287
Erratum
Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010 FREE
R Luoto, J Raitanen, E Pukkala and A Anttila
Br J Cancer 91: 1979; doi:10.1038/sj.bjc.6602288
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
